TABLE 1.
General sample information |
Age range (y) |
MRI information |
Type of MRI data |
Objective sleep assessment |
Sleep questionnaires and genetic information |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample # |
Country | Institute | Disorder | F/M ratio (~) |
# Number of subjects |
Children (<11) |
Adolescents (11-18) |
Younger Adults (18-55) |
Older Adults (>55) |
Field strength (T) |
T1-w | DTI | rs-fMRI | MRS | Task fmri |
Acti- graphy |
Poly- somno- graphy |
GWAS | PSQI | sleep diary |
AHI | ISI | BERLIN | ASWS | CSM | ELIT | GSAQ | HSDQ | MEQ | JHRLSS | RLS- DI |
KSQ | KSNS | DTS | Other |
1 | Kermanshah, iran | KUMS | Insomnia | 1.660 | 57 | --- | --- | 57 | 11 | 1.5 | 76 | 43 | 57 | 0 | 0 | 0 | 57 | 0 | 76 | 0 | 0 | 23 | 0 | 0 | 0 | 0 | 57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ESS, HAM-A, HAM-D, BAI, BDI |
Kermanshah, iran | KUMS | OSA | 0.272 | 14 | --- | --- | 7 | 7 | 1.5 | 14 | 14 | 14 | 0 | 0 | 0 | 14 | 0 | 14 | 0 | 14 | 0 | 14 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ESS | |
Kermanshah, iran | KUMS | Healthy controls | 1.290 | 53 | --- | --- | 67 | 11 | 1.5 | 72 | 48 | 53 | 0 | 0 | 0 | 0 | 0 | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ESS, HAM-A, HAM-D, BAI, BDI | |
2 | Milano, Italy | IRCCS | Bipolar | 0.620 | 142 | --- | --- | 105 | 37 | 3 | 75 | 75 | 75 | 0 | 50 | 142 | 0 | 0 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142 | 0 | 0 | 0 | 0 | 0 | HAM-D, DSM-V |
Milano, Italy | IRCCS | MDD | 0.860 | 49 | --- | --- | 35 | 14 | 3 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | HAM-D, DSM-V | |
Milano, Italy | IRCCS | Healthy controls | 0.650 | 20 | --- | --- | 14 | 6 | 3 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | HAM-D, DSM-V | |
3 | Singapore | NUS | Healthy controls | 0.500 | 52 | --- | 52 | --- | --- | 3 | 52 | 0 | 52 | 0 | 0 | 52 | 52 | 0 | 52 | 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 52 | 0 | 0 | 0 | 0 | 0 | |
Singapore | NUS | Sleep deprivation in healthy participants | 0.480 | 35 | --- | --- | 35 | --- | 3 | 35 | 0 | 35 | 0 | 0 | 0 | 0 | 0 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
4 | Greifswald, Germany | DPPUMG | Insomnia disorders | 0.850 | 1,217 | --- | --- | 676 | 541 | 1.5 | 841 | 0 | 0 | 0 | 0 | 0 | 1,062 | 1,150 | 1,007 | 0 | 1,062 | 1,217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,175 | 0 | 0 | 0 | ESS, CTQ, PHQ–9, BDI–2, SF–12, TAS–20 |
Greifswald, Germany | DPPUMG | OSA | 0.850 | 1,109 | --- | --- | 592 | 517 | 1.5 | 763 | 0 | 0 | 0 | 0 | 0 | 1,109 | 1,046 | 913 | 0 | 1,109 | 1,062 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,067 | 0 | 0 | 0 | ESS, CTQ, PHQ–9, BDI–2, SF–12, TAS–20 | |
5 | Stockholm, Sweden | Karolinska Institutet | Sleep restriction in healthy participants | 1.047 | 84 | --- | --- | 47 | 39 | 3 | 86 | 0 | 68 | 0 | 86 | 0 | 86 | 0 | 84 | 86 | 0 | 86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86 | 86 | 86 | HADS, frozen plasma, frozen DNA |
Stockholm, Sweden | Karolinska Institutet | Sleep deprivation in healthy participants | 0.650 | 47 | --- | --- | 47 | --- | 3 | 47 | 47 | 38 | 0 | 38 | 26 | 0 | 0 | 38 | 38 | 0 | 47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47 | 0 | 0 | HADS, frozen plasma, frozen DNA | |
6 | Rotterdam, Netherlands | Erasmus MC | Population-based sample | 1.446 | 14,926 | --- | --- | 1606 | 13,320 | 1.5 | 5,286 | 5,286 | 2,668 | 0 | 0 | 2,430 | 912 | 11,502 | 9,950 | 2,430 | 796 | 0 | 926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | IRLS |
7 | Freiburg, Germany | UFMC | Insomnia | 1.770 | 50 | --- | --- | --- | --- | 3 | 50 | 24 | 20 | 20 | 28 | 0 | 42 | 0 | 50 | 50 | 42 | 42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Freiburg, Germany | UFMC | Healthy controls | 1.300 | 47 | --- | --- | --- | --- | 3 | 47 | 35 | 20 | 20 | 38 | 0 | 39 | 0 | 47 | 47 | 39 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
8 | Amsterdam, Netherlands | NINS | Insomnia | 2.984 | 251 | --- | --- | 164 | 87 | 1.5,3 | 251 | 251 | 251 | 0 | 251 | 251 | 251 | 0 | 251 | 251 | 0 | 251 | 251 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Amsterdam, Netherlands | NINS | Healthy controls | 2.406 | 109 | --- | --- | 76 | 33 | 1.5, 3 | 109 | 109 | 109 | 0 | 109 | 109 | 109 | 0 | 109 | 109 | 0 | 109 | 109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
9 | France | NeuroSpin | Bipolar | 0.643 | 28 | --- | --- | 28 | --- | 3 | 28 | 28 | 28 | 0 | 0 | 28 | 0 | 28 | 28 | 28 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
France | NeuroSpin | Healthy controls | 0.867 | 28 | --- | --- | 28 | --- | 3 | 28 | 28 | 28 | 0 | 0 | 28 | 0 | 28 | 28 | 28 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
10 | Melbourne, Victoria, Australia | Deakin University | ADHD | 0.377 | 84 | --- | 84 | --- | --- | 3 | 84 | 84 | 84 | 0 | 0 | 0 | 0 | 84 | 0 | 0 | 0 | 0 | 0 | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Melbourne, Victoria, Australia | Deakin University | Healthy controls | 0.900 | 76 | --- | 76 | --- | --- | 3 | 76 | 76 | 76 | 0 | 0 | 0 | 0 | 76 | 0 | 0 | 0 | 0 | 0 | 76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
11 | Amsterdam, Netherlands | AMC | ADHD | 0.000 | 48 | 21 | 27 | --- | --- | 3 | 48 | 48 | 48 | 0 | 48 | 48 | 0 | 0 | 0 | 48 | 0 | 0 | 0 | 0 | 0 | 48 | 0 | 48 | 0 | 48 | 0 | 0 | 0 | 0 | |
12 | Houston, Texas, Texas | UTHSCH | BD, MDD | 1.829 | 99 | --- | --- | 62 | 37 | 3 | 99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Houston, Texas, Texas | UTHSCH | Healthy controls | 1.579 | 49 | --- | --- | 28 | 21 | 3 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
13 | California, United States | UCSF | MDD | 1.895 | 55 | --- | 55 | --- | --- | 3 | 53 | 50 | 49 | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PHQ–9, RADS–2, CDRS-R |
California, United States | UCSF | Healthy controls | 1.400 | 24 | --- | 24 | --- | --- | 3 | 22 | 19 | 21 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PHQ–9, RADS–2, CDRS-R | |
14 | Groningen, Netherlands | UG | MDD | 2.833 | 23 | --- | --- | 18 | 5 | 3 | 23 | 18 | 0 | 0 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | BDI-II, FAS–10, TAS–20 |
Groningen, Netherlands | UG | Healthy controls | 2.429 | 24 | --- | --- | 18 | 6 | 3 | 24 | 20 | 0 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | BDI-II, FAS–10, TAS–20 | |
15 | Brisbane, Australia | UQL | Healthy controls | 0.936 | 422 | 174 | 248 | --- | --- | 3 | 406 | 395 | 310 | 0 | 0 | 188 | 0 | 0 | 0 | 247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PDSS |
16 | Maryland, United States | UMSOM | Family-based recruitment sample focused on cross-diagnostic illnesses research | 1.363 | 560 | --- | --- | 420 | 140 | 3 | 560 | 560 | 560 | 560 | 560 | 0 | 0 | 560 | 560 | 560 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PSS, LIS |
17 | Melbourne, Victoria, Australia | ACU | Sleep deprivation in healthy participants | 1.000 | 20 | --- | --- | 20 | --- | 3 | 20 | 0 | 0 | 0 | 20 | 20 | 0 | 0 | 20 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Melbourne, Victoria, Australia | ACU | Healthy Controls | 1.030 | 67 | --- | --- | --- | 67 | 3 | 67 | 67 | 67 | 0 | 0 | 0 | 0 | 0 | 67 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
18 | Oslo, Norway | OUH | Sleep deprivation in healthy participants | 0.600 | 25 | --- | --- | 25 | --- | 3 | 25 | 25 | 25 | 0 | 0 | 25 | 0 | 25 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Oslo, Norway | OUH | Healthy Controls | 0.600 | 25 | --- | --- | 25 | --- | 3 | 25 | 25 | 25 | 0 | 0 | 25 | 0 | 25 | 25 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | PVT, HMEQ, BIS | |
19 | Trondheim, Norway | NTNU | Habitual sleep patterns + deprivation in healthy participants | 0.494 | 92 | --- | --- | 92 | --- | 3 | 88 | 88 | 88 | 0 | 88 | 88 | 0 | 0 | 92 | 88 | 0 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 92 | 0 | 0 | 0 | 92 | 0 | ESS, FSS, CFS, PSS, MCQ–30, CAS–1, BRIEF-A, HSCL-25, NEO-PI-3, neuropsychological testing |
20 | Liège, Belgium | GIGA-CRC | Healthy Controls | 2.000 | 90 | --- | --- | --- | 90 | 3 | 90 | 90 | 90 | 0 | 90 | 90 | 90 | 0 | 90 | 90 | 0 | 90 | 0 | 0 | 0 | 0 | 0 | 0 | 90 | 0 | 0 | 0 | 90 | 0 | Educational level, ESS, BDI, BAI, STAI Y-A, MILL HILL, SPAQ, PSS, (BMI, waist to hip, blood pressure), leasure, sport, profession, NEO-FFI, SF36, neuropsychological testing |
Liège, Belgium | GIGA-CRC | Healthy Controls | 2.194 | 101 | --- | --- | --- | 101 | 3 | 101 | 101 | 0 | 0 | 0 | 101 | 101 | 101 | 101 | 101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 101 | 0 | 0 | 0 | 101 | 0 | As above | |
Liège, Belgium | GIGA-CRC | sleep deprivation in healthy participants | 0.000 | 364 | --- | --- | 364 | --- | 3 | 360 | 360 | 0 | 0 | 0 | 364 | 364 | 364 | 364 | 364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 364 | 0 | 0 | 0 | 364 | 0 | As above |
ACU, Australian Catholic University; AHI, apnea-hypopnea index; AMC, Academic Medical Center; ASWS, Adolescent Sleep-Wake Scale; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BIS, Bergen Insomnia Scale; BRIEF-A, Behaviour Rating Inventory of Executive Function for Adults; CAS, Confirmation of Acceptance for Studies; CDRS-R, Children's Depression Rating Scale, Revised; CFS, Chalder Fatigue Scale; CSM, Composite Scale of Morningness; CTQ, Childhood Trauma Questionnaire; DPPUMG, Department of Psychiatry and Psychotherapy, University Medicine Greifswald; DSM-V, Diagnostic and Statistical Manual of Mental Disorders; DTS, Diurnal Type Scale; ELIT, Evaluation List Insomnia Therapy; Erasmus MC, Erasmus University Medical Center; ESS, Epworth Sleepiness Scale; FAS, Fatigue Assessment Scale; FSS, Fatigue Severity Scale; GIGA-CRC, GIGA-Cyclotron Reaserch Center in Vivo Imaging; GSAQ, Global Sleep Assessment Questionnaire; GWAS, Genome-Wide Association Study; HADS, Hospital Anxiety and Depression Scale; HAM-A, Hamilton Rating Scale for Anxiety; HAM-D, Hamilton Rating Scale for Depression; HMEQ, Horne-Østberg Morningness-Eveningness Questionnaire; HSCL-25, Hopkins Symptom Checklist; HSDQ, Holland Sleep Disorders Questionnaire; IRCCS, Scientific Institute San Raffaele Hospital; IRLS, International Restless Legs Scale; ISI, Insomnia Severity Index; JHRLSS, Johns Hopkins Restless Legs Severity Scale; KSNS, Karolinska Sleepiness Scale; KSQ, Karolinska Sleep Questionnaire; KUMS, Sleep Disorders Research Center, Kermanshah University of Medical Sciences; LIS, Laboratory information system; LSI, Lifetime Stressor Inventory; MCQ-30, Metacognition Questionnaire; MEQ, Morningness-Eveningness Questionnaire; NEO-PI, Neo Personality Inventory-Revised; NINS, Netherlands Institute for Neuroscience; NTNU, Norges Teknisk-Naturvitenskapelige Universitet; NUS, National University of Singapore; OUH, Oslo University Hospital; PDSS, Paediatric Daytime Sleepiness Scale; PHQ-9, Patient Health Questionnaire 9; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; PVT, Psychomotor vigilance test; RADS, Reynolds Adolescent Depression Scale; RLS-DI, Restless Legs Syndrome-Diagnostic Index; SF12, Short Form (12); SPAQ, Seasonal Pattern Assessment Questionnaire; STAI, State-Trait Anxiety Inventory; STAI, State-Trait Anxiety Inventory; TAS-20, Toronto Alexithymia Scale; UCSF, University of California San Francisco; UFMC, University of Freiburg Medical Center; UG, University of Groningen; UMSOM, University of Maryland School of Medicine; UQL, University of Queensland; UTHSCH, The University of Texas Health Science Center at Houston.